aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Palleon Pharmaceuticals is a biotechnology company focused on developing glycoimmune checkpoint inhibitors to treat cancer and autoimmune diseases. The company's core mission is to harness the power of glycobiology to create innovative immuno-oncology drugs and therapies. Based in Massachusetts, Palleon Pharmaceuticals aims to revolutionize cancer treatment through glycan editing, targeting the glycan structures on cell surfaces to modulate immune responses.
Palleon Pharmaceuticals has made significant strides in the field of immuno-oncology, leveraging advanced glycobiology techniques to develop novel therapeutic approaches. The company has attracted attention for its pioneering work in glycan editing, positioning itself as a leader in the next frontier of cancer treatment. Palleon's impact is underscored by its commitment to improving patient outcomes and advancing the science of immunotherapy.
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Immuno-Oncology Drugs
Technology
Biotech
Tags
Healthtech
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Palleon Pharmaceuticals founded?
Palleon Pharmaceuticals was founded in 2016.
Where is Palleon Pharmaceuticals’s headquarters located?
Palleon Pharmaceuticals’s headquarters is located in Waltham, MA, US.
When was Palleon Pharmaceuticals’s last funding round?
Palleon Pharmaceuticals’s most recent funding round was for $100M (USD) in September 2020.
How many employees does Palleon Pharmaceuticals have?
Palleon Pharmaceuticals has 47 employees as of Feb 5, 2024.
How much has Palleon Pharmaceuticals raised to-date?
As of July 05, 2023, Palleon Pharmaceuticals has raised a total of $147.6M (USD) since Sep 17, 2020.
Add Comparison
Total Raised to Date
$147.6M
USD
Last Update Sep 17, 2020
Last Deal Details
$100M
USD
Sep 17, 2020
Series B
Total Employees Over Time
47
As of Feb 2024
Palleon Pharmaceuticals Address
266 Second Ave
Waltham,
Massachusetts
02451
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts